Oncogenic transcription factors (TFs), such as the androgen receptor (AR), cooperate with epigenetic coregulators at cancer-specific enhancer complexes, or neo-enhanceosomes, to drive oncogene expression by promoter looping4–9. The gene discussed is AR; the disease is cancer.